Byrnes Michael 4
4 · eFFECTOR Therapeutics, Inc. · Filed Jun 7, 2022
Insider Transaction Report
Form 4
Byrnes Michael
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-06-07$1.33/sh+25,000$33,263→ 29,233 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.275 to $1.360. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.